Competition Law is catching pharma companies out

摘要

In jurisdictions across the world, the pharmaceutical industry has come under the scrutiny of inquiries and legal actions involving the application of Competition Law. This summer has seen an upsurge of antitrust activity. A host of regulatory investigations and lawsuits have been commenced against pharma industry players and (in some cases) fines levied in the EU and US.